Diagnamed Holdings Corp.

Equities

DMED

CA25245D1033

Software

Market Closed - Canadian Securities Exchange 11:16:25 2024-04-26 am EDT 5-day change 1st Jan Change
0.04 CAD -11.11% Intraday chart for Diagnamed Holdings Corp. +14.29% +33.33%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Diagnamed?s Brain Age® Brain Health Ai Platform Accomplishes Clinical Validation Milestone with Peer-Reviewed Paper CI
DiagnaMed Holdings Corp. Announces Canadian Launch of BRAIN AGE® Brain Health AI CI
Diagnamed Holdings Corp. Adds New Launch Site of CERVAI Brain Health AI CI
DiagnaMed Announces BRAIN AGE Trademark Registration Approved by CIPO MT
DiagnaMed Holdings Corp. Announces Brain AGE Trademark Registration Approved by Canadian Intellectual Property Office CI
DiagnaMed Holdings Corp. Accelerates Commercialization Initiatives of CERVAI Brain Health AI Solution CI
Diagnamed Holdings Corp. Reports Earnings Results for the First Quarter Ended December 31, 2023 CI
DiagnaMed Announces Test Launch of CERVAI Brain Health in University Brain Health Center CI
Diagnamed Holdings Corp. Reports Earnings Results for the Full Year Ended September 30, 2023 CI
Diagnamed Holdings Corp. Announces Pilot Launch of Cervai? Brain Health Ai Solution CI
DiagnaMed Accelerates Commercialization of CERVAI(TM) Brain Health AI Platform with Acceptance into the SOPHIE Program CI
DiagnaMed Holdings Corp. Launches New Healthcare Provider Network Program for CERVAI?? Brain Health AI Platform in Canada and the USA CI
DiagnaMed Provides Update for its Brain Health AI Platform MT
DiagnaMed Holdings Corp. Provides Update for its Brain Health AI Platform, CERVAI CI
Diagnamed Holdings Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2023 CI
DiagnaMed Provides Update on CERVAI, a Brain Health AI Platform MT
DiagnaMed Provides Update on CERVAIâ„¢, a Brain Health AI Platform Leveraging Generative AI CI
DiagnaMed Holdings Corp. Launches A Generative Artificial Intelligence Medical Chatbot, Dr. GenAI CI
DiagnaMed Holdings Corp. Launches FormGPT.io, a Generative AI Healthcare Solution CI
DiagnaMed Holdings Corp. Launches PalGPT.ai, a Generative AI Brain Health Solution CI
Diagnamed Launches “Health GenAI”, A New Division for Generative AI Healthcare Solutions CI
Diagnamed Enters into License Agreement with University of Miami for Brain Health Platform for Integration with Cervai(Tm) CI
Diagnamed Prioritizes Development and Commercialization Initiatives for CERVAI(TM), A Brain Health AI Platform Leveraging Generative AI CI
Diagnamed Holdings Corp. Announces Board Changes CI
DiagnaMed Holdings Corp. Incorporates OpenAI's ChatGPT into BRAIN AGE AI Product Suite CI
Chart Diagnamed Holdings Corp.
More charts
DiagnaMed Holdings Corp. is a Canada-based generative artificial intelligence healthcare company. The Company is focused on developing and commercializing CERVAI, a proprietary brain health artificial intelligence (AI) platform. CERVAI leverages generative AI that predicts and monitors brain age and provides actionable insights and tools to diagnose, prevent or improve cognitive decline for mental health and neurodegenerative disorders. The Company is developing and commercializing a suite of generative AI solutions powered by OpenAI's ChatGPT to support the healthcare market in improving patient outcomes, operational workflow and efficiency. AI Medical Chatbot is a personal medical chatbot designed to give people a way to obtain fast and personalized medical information based on a person’s unique medical condition.
More about the company
  1. Stock Market
  2. Equities
  3. DMED Stock
  4. News Diagnamed Holdings Corp.
  5. DiagnaMed Announces BRAIN AGE Trademark Registration Approved by CIPO